FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clots

WPVI

Real
Joined
Apr 15, 2022
Messages
4,127
Reaction score
3
BC
฿0
Dividends
0
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

Continue reading...
 

Similar threads

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
Replies
0
Views
173
WPLG
FDA Proposes Ending Use of Oral Phenylephrine as OTC Nasal Decongestant
Replies
0
Views
214
Hacker News
After decades, FDA moves to pull ineffective decongestant off shelves
Replies
0
Views
223
Hacker News
FDA Permits Marketing of Digital Game to Improve Attention in ADHD Children
Replies
0
Views
198
Hacker News
FDA approves a novel drug for schizophrenia, a potential 'game changer'
Replies
0
Views
195
Hacker News

Users who are viewing this thread

Total: 2 (members: 0, guests: 2)
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more…